Question 1

What are the key details for the project “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)”?

Accepted Answer

The project “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Question 2

What is the latest status of the project “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)”?

Accepted Answer

The status recorded for “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)” is archived.

Question 3

Who are the main government, EPC, and private stakeholders for “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)”?

Accepted Answer

Taiyo maps the stakeholders of “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)”: government bodies (National Institutes of Health (NIH), US Department of Health and Human Services (HHS), US Government).

Question 4

What is the budget and commercial profile for the project “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)”?

Accepted Answer

Taiyo normalizes the budget of “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)” to USD 7000000.

Question 5

Where can I verify the source and access all details for “Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)”?

Accepted Answer

This Taiyo project page references Grants.gov along with the original URL (https://www.grants.gov/web/grants/view-opportunity.html?oppId=290398). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	archived
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	The purpose of this Funding Opportunity Announcement (FOA) is to complete treatment of the participants recruited into the Preventing Early Renal Loss in Diabetes (PERL) Study and to analyze the outcomes of the trial. PERL is a randomized, double-blind trial to test whether the medication, allopurinol, can slow the progression of kidney disease in people with type 1 diabetes and early diabetic kidney disease.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)

Project Information FAQ

Project Information